Lonza and NeuroSense Therapeutics Ltd., a company developing treatments for amyotrophic lateral sclerosis (ALS) and other severe neurodegenerative diseases, have entered a collaboration to evaluate biological changes occurring in people with neurodegenerative diseases, including ALS.
Lonza to manufacture Acumen's monoclonal antibody, sabirnetug (ACU193), for clinical development and commercialization, if approvedSabirnetug is the first monoclonal antibody candidate to enter the...
WCG Launches New Application on Its ClinSphere Technology Platform
Lonza names Siegfried Holding boss as new CEO
Lonza, a global manufacturing partner to the pharmaceutical, biotech and nutraceutical markets, has expanded its service offering for spray-drying of proteins for pulmonary delivery.
Swiss contract drug manufacturer Lonza said on Wednesday it would buy one of the world's largest manufacturing sites for biologic drugs
Epsilogen and Lonza Announce Successful Large-Scale GMP Manufacturing of MOv18
Lonza chairman to step down, drugmaker confirms targets, shares soar
Days after Lonza confirmed its plan to close a manufacturing facility in Hayward, California, the CDMO powerhouse said that it was shuttering another plant in Guangzhou, China.